miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 18, 2026

63% of Americans Could Cover a $400 Emergency. Far Fewer Could Cover One Month of Retirement.

View original at finance.yahoo.com
63% of Americans Could Cover a $400 Emergency. Far Fewer Could Cover One Month of Retirement. Quick Read The median 401(k) balance of $44,115 generates just $147 a month under the 4% rule, against typical retiree spending of $5,000 per month…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 63% of adults could cover an unexpected $400 expense with cash or its equivalent, per the 2026 report on 2025 household well-being.

    60% confidence

  • SmartAsset's free tool can match users with a vetted, fiduciary financial advisor in minutes.

    60% confidence

  • Housing accounted for $3,950.3 billion in annualized personal consumption spending in May 2026, and healthcare accounted for $3,716 billion; combined with food, essential categories account for roughly 42% of total personal consumption.

    60% confidence

  • The median 401(k) balance across plans Vanguard administers is $44,115, alongside an average of roughly $167,970.

    60% confidence

  • Typical retiree household spending is near $5,000 per month, with housing, healthcare, and food accounting for most of it.

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com